Dosing regimen associated with longacting injectable paliperidone esters

Details for Australian Patent Application No. 2010313290 (hide)

Owner Janssen Pharmaceutical NV

Inventors Lewyn-Briscoe, Peter H.; GassmannMayer, Cristiana; Gopal, Srihari; Hough, David W.; Remmerie, Bart M. M.; Samtani, Mahesh N.

Agent Shelston IP

Pub. Number AU-A-2010313290

PCT Pub. Number WO2011/053829

Priority 61/256,696 30.10.09 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053829 Priority application(s): WO2011/053829

21 June 2012 Alteration of Name

  The name of the applicant has been altered to Janssen Pharmaceutica NV

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313292-Methods for diagnosing irritable bowel syndrome

2010313282-Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same